Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP
Professor of Pharmacy Practice
Pharmacy Clinical & Admin Sci
Phone (405) 271-2730
Fax (405) 271-6750
Office O'Donoghue Research Bldg; 1122 NE 13th St., Ste. 4415, OKC 73117
Email Peter-Johnson@ouhsc.edu
Summary
- President's Associate Presidential Professor
- Director, PGY2 Pediatric Pharmacy Residency
- Director, Pediatric Pharmacotherapy Degree Option
Publications & Presentations
- 1. Johnson P N, Miller J L. Peer Review as a Professional Obligation: Steps and Tips to Becoming a High-Quality Reviewer. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2024; 29 : 570-577
2. Parman A, Miller J L, Neely S, Johnson P N, Gupta N. Rates of Stress Ulcer Prophylaxis Deprescribing in Children Receiving Usual versus High-Dose Corticosteroids in the Pediatric Intensive Care Unit with Status Asthmaticus. Hospital pharmacy. 2024; 59 : 677-683
3. Patel K, Thomson S, Vijayan M, Makoni M, Johnson P N, Stephens K, Neely S, Miller J L. Vasopressin induced hyponatremia in infants <3 months of age in the neonatal intensive care unit. Frontiers in Pediatrics. 2024; 12 : 1-8
4. Chang E, Parman A, Johnson P N, Stephens K, Neely S, Dasari N, Kassa N, Miller J L. Gabapentin for Delirium in Infants in the Neonatal Intensive Care Unit. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2024; 29 : 487-493
5. Ropp D L, Johnson P N, Stephens K, Neely S, Chaaban H, Miller J L. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of perinatology : official journal of the California Perinatal Association. 2024; 44 : 1478-1484
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 26. Pediatric Pharmacy Advocacy Group. Presidential Citation. Date: 2013.
27. American College of Clinical Pharmacy. Volunteer Member Recognition Nominee. Date: 2013.
28. Oklahoma Society of Health-System Pharmacists. Oustanding Service Award. Date: 2013.
29. University of Oklahoma College of Pharmacy. Rho-Chi--Inductee. Date: 2013.
30. Oklahoma Society of Health-System Pharmacists. Outsanding Service Award. Date: 2011.
Education
- 1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.
2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.
3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.
4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.
Administrative Assignments
no results